We don't yet have the research to know whether long-term metabolic improvements ultimately outweigh early appetite suppression risk
They also carry a boxed warning about thyroid C-cell tumor risk and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Youll want to consult your healthcare team about which medication may be most appropriate for your specific health situation
Diabetes management issues for patients with chronic kidney disease
Tirzepatide and weight loss in general tend to lower blood pressure
Adverse effects associated with dosing errors have included nausea, vomiting, abdominal pain, fainting, headache, dehydration, gallstones, and inflammation of the pancreas